{"transactions":[{"id":4615630,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22963,"kind":"person","name":"Korczynski Sherry","position":1,"cik":"0002026090","reported_name":"Korczynski Sherry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-09-11T15:07:53.000Z","date":"2026-09-09","kind":"exercise","planned":true,"acquired":false,"shares":8750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":26250,"derivative":{"exercise_price":2.65,"expiration_date":"2035-03-07","underlying":"Common Stock","underlying_shares":8750},"source":{"system":"sec-edgar","filing":"0001214659-26-011596","document":"marketforms-73981.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2026090/000121465926011596/marketforms-73981.xml","form_type":"4"}},{"id":4615629,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22963,"kind":"person","name":"Korczynski Sherry","position":1,"cik":"0002026090","reported_name":"Korczynski Sherry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-09-11T15:07:53.000Z","date":"2026-09-09","kind":"sale","planned":true,"acquired":false,"shares":8750,"price":5.22,"value":45675.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4."}],"balance_after":235689,"source":{"system":"sec-edgar","filing":"0001214659-26-011596","document":"marketforms-73981.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2026090/000121465926011596/marketforms-73981.xml","form_type":"4"}},{"id":4615628,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22963,"kind":"person","name":"Korczynski Sherry","position":1,"cik":"0002026090","reported_name":"Korczynski Sherry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-09-11T15:07:53.000Z","date":"2026-09-09","kind":"exercise","planned":true,"acquired":true,"shares":8750,"price":2.65,"value":23187.5,"ownership":{"direct":true},"balance_after":244439,"source":{"system":"sec-edgar","filing":"0001214659-26-011596","document":"marketforms-73981.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2026090/000121465926011596/marketforms-73981.xml","form_type":"4"}},{"id":685787,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22963,"kind":"person","name":"Korczynski Sherry","position":1,"cik":"0002026090","reported_name":"Korczynski Sherry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-08-17T21:33:35.000Z","date":"2026-08-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":2714,"price":4.25,"value":11534.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units (\"RSUs\") previously granted to the Reporting Person."}],"balance_after":235689,"source":{"system":"sec-edgar","filing":"0001214659-26-010474","document":"marketforms-73774.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2026090/000121465926010474/marketforms-73774.xml","form_type":"4"}},{"id":744962,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22963,"kind":"person","name":"Korczynski Sherry","position":1,"cik":"0002026090","reported_name":"Korczynski Sherry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-06-09T18:48:07.000Z","date":"2026-06-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":2714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units (\"RSUs\") previously granted to the Reporting Person."}],"balance_after":238403,"source":{"system":"sec-edgar","filing":"0001214659-26-007262","document":"marketforms-73366.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2026090/000121465926007262/marketforms-73366.xml","form_type":"4"}},{"id":809763,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22963,"kind":"person","name":"Korczynski Sherry","position":1,"cik":"0002026090","reported_name":"Korczynski Sherry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Performance Stock Units","published_at":"2026-04-13T19:52:27.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":67500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 was filed late due to an inadvertent administrative oversight."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PSU represents a contingent right to receive one share of the Company's common stock. The PSUs measure performance from March 7, 2025 (Grant Date) through March 7, 2028 and, if earned, vest 100% on March 7, 2028. \"Performance Price\" means (i) the 30-day average Nasdaq closing price ending on the last day of the period from the Grant Date through the day before the second anniversary (First Pricing Period) and (ii) the highest 30-day average Nasdaq closing price during the period from the second through the third anniversary (Second Pricing Period)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each PSU represents a contingent right to receive one share of the Company's common stock. The PSUs measure performance from March 7, 2025 (Grant Date) through March 7, 2028 and, if earned, vest 100% on March 7, 2028. \"Performance Price\" means (i) the 30-day average Nasdaq closing price ending on the last day of the period from the Grant Date through the day before the second anniversary (First Pricing Period) and (ii) the highest 30-day average Nasdaq closing price during the period from the second through the third anniversary (Second Pricing Period)."}],"balance_after":67500,"derivative":{"expiration_date":"2028-03-07","underlying":"Common Stock","underlying_shares":67500},"source":{"system":"sec-edgar","filing":"0001214659-26-004593","document":"marketforms-72933.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2026090/000121465926004593/marketforms-72933.xml","form_type":"4"}},{"id":849098,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22963,"kind":"person","name":"Korczynski Sherry","position":1,"cik":"0002026090","reported_name":"Korczynski Sherry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-03-11T16:51:23.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":42500,"price":4.29,"value":182325.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":42500,"derivative":{"exercise_price":4.29,"expiration_date":"2036-03-09","underlying":"Common Stock","underlying_shares":42500},"source":{"system":"sec-edgar","filing":"0001214659-26-003142","document":"marketforms-72468.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2026090/000121465926003142/marketforms-72468.xml","form_type":"4"}},{"id":849097,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22963,"kind":"person","name":"Korczynski Sherry","position":1,"cik":"0002026090","reported_name":"Korczynski Sherry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-11T16:51:23.000Z","date":"2026-03-10","kind":"sale","planned":false,"acquired":false,"shares":15741,"price":4.173,"value":65687.193,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $4.17 to $4.32. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":241117,"source":{"system":"sec-edgar","filing":"0001214659-26-003142","document":"marketforms-72468.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2026090/000121465926003142/marketforms-72468.xml","form_type":"4"}},{"id":849096,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22963,"kind":"person","name":"Korczynski Sherry","position":1,"cik":"0002026090","reported_name":"Korczynski Sherry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-11T16:51:23.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":256858,"source":{"system":"sec-edgar","filing":"0001214659-26-003142","document":"marketforms-72468.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2026090/000121465926003142/marketforms-72468.xml","form_type":"4"}},{"id":1065556,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22963,"kind":"person","name":"Korczynski Sherry","position":1,"cik":"0002026090","reported_name":"Korczynski Sherry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-08-15T12:41:12.000Z","date":"2025-08-14","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":181858,"source":{"system":"sec-edgar","filing":"0001214659-25-012304","document":"marketforms-70071.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2026090/000121465925012304/marketforms-70071.xml","form_type":"4"}},{"id":1116616,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22963,"kind":"person","name":"Korczynski Sherry","position":1,"cik":"0002026090","reported_name":"Korczynski Sherry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Sales and Marketing"}}],"security":"Common Stock","published_at":"2025-06-10T18:12:59.000Z","date":"2025-06-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":2714,"price":3.54,"value":9607.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units (\"RSUs\") previously granted to the Reporting Person."}],"balance_after":156858,"source":{"system":"sec-edgar","filing":"0001214659-25-009047","document":"marketforms-69905.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2026090/000121465925009047/marketforms-69905.xml","form_type":"4"}},{"id":1212768,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22963,"kind":"person","name":"Korczynski Sherry","position":1,"cik":"0002026090","reported_name":"Korczynski Sherry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Sales and Marketing"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-03-11T21:48:13.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":35000,"derivative":{"exercise_price":2.65,"expiration_date":"2035-03-07","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001214659-25-004224","document":"marketforms-68572.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2026090/000121465925004224/marketforms-68572.xml","form_type":"4"}},{"id":1212767,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22963,"kind":"person","name":"Korczynski Sherry","position":1,"cik":"0002026090","reported_name":"Korczynski Sherry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Sales and Marketing"}}],"security":"Common Stock","published_at":"2025-03-11T21:48:13.000Z","date":"2025-03-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":5428,"price":2.65,"value":14384.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units (\"RSUs\") previously granted to the Reporting Person."}],"balance_after":159572,"source":{"system":"sec-edgar","filing":"0001214659-25-004224","document":"marketforms-68572.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2026090/000121465925004224/marketforms-68572.xml","form_type":"4"}},{"id":1212766,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22963,"kind":"person","name":"Korczynski Sherry","position":1,"cik":"0002026090","reported_name":"Korczynski Sherry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Sales and Marketing"}}],"security":"Common Stock","published_at":"2025-03-11T21:48:13.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":165000,"source":{"system":"sec-edgar","filing":"0001214659-25-004224","document":"marketforms-68572.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2026090/000121465925004224/marketforms-68572.xml","form_type":"4"}},{"id":1483813,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":22963,"kind":"person","name":"Korczynski Sherry","position":1,"cik":"0002026090","reported_name":"Korczynski Sherry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Sales and Marketing"}}],"security":"Common Stock","published_at":"2024-06-11T16:36:13.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001214659-24-010798","document":"marketforms-66306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2026090/000121465924010798/marketforms-66306.xml","form_type":"4"}}]}